ncats advisory council june 2015 concept clearance
play

NCATS Advisory Council June 2015 Concept Clearance DEVELOPMENT OF - PowerPoint PPT Presentation

NCATS Advisory Council June 2015 Concept Clearance DEVELOPMENT OF STEM CELL- OR IPS CELL-BASED ASSAYS FOR COMPOUND TOXICITY EVALUATION MENGHANG XIA, PH.D. LILI M. PORTILLA, MPA ANNA ROSSOSHEK, MS, MBA Description of the Goal For the


  1. NCATS Advisory Council June 2015 Concept Clearance DEVELOPMENT OF STEM CELL- OR IPS CELL-BASED ASSAYS FOR COMPOUND TOXICITY EVALUATION MENGHANG XIA, PH.D. LILI M. PORTILLA, MPA ANNA ROSSOSHEK, MS, MBA

  2. Description of the Goal • For the Phase I cont ract , t he goal is t o develop t oxicological relat ed assays in homogenous format t hat can be used in human st em cell or iPS -derived cells wit h short t ime compound t reat ment . • For Phase II cont ract s, t he goal is t o miniat urize t he assays int o 384-well and 1536-well plat e format .

  3. Description of the Outcome • Potential impact?  Assays wit h various endpoint s using iPS -derived cells in a 1536-well plat e format will great ly speed up t he capacit y of screening environment al chemicals.  Also, using iPS -derived st em cells will make t his screening approach even more relevant and t he dat a more valuable in order t o est ablishing predict ive models of how t hese chemical compounds affect human t issues and pat hways.

  4. Description of the Outcome • Criteria for evaluating success?  The number of solicit at ions received wit h innovat ive approaches.  Technical achievement in growing and ut ilizing iPS derived st em cells for HTS in miniat urized assay plat es.  A viable iPS / st em cell assays t hat meet s all t he appropriat e charact erizat ion crit eria, i.e. sensit ivit y, Z’ value >0.5  Demonst rat es significant ut ilit y of t he assay by charact erizing it s abilit y t o det ect t he effect s of compounds known t o affect t he pat hway/ cellular phenot ype.

  5. Description of the Initiative • What is the major obstacle/opportunity to address?  Using iPS cells in toxicological screens therefore making them more relevant in-vitro model systems for the future. • Relevance to the NCATS’ mission?  These assays would be the basis for screening programs such as the Tox21 Program and other qHTS initiatives. • Brief summary of ongoing research/activity in this area?  This proposed contract topic is closely related to a previous S BIR contract topic entitled, “ Assay Development for High-Throughput S creening of Chemicals of Toxicological Concern” which has successfully produced several new assays to be commercialized by small businesses.

Recommend


More recommend